NCT06042192

Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Teikoku Seiyaku Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Accepted

Summary

This study is a multi center, multiple dose, open label trial to evaluate the adhesion of TK-254RX in healthy volunteers. The primary purpose of this study is to evaluate the adhesion of TK-254RX. Secondary purpose is to show TK-254RX is safe and to explore and compare adhesion assessment methods.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	TK-254RX	Two TK-254RX per day to predetermined application site

Timeline

• Start date: 2023-09-14
• Primary completion: 2023-11-09
• Completion: 2023-12-13
• First posted: 2023-09-18
• Last updated: 2024-04-12

Locations

4 sites across 1 country: Germany

Regulatory

• FDA-regulated drug study